supplysidesj.com
Three-strain probiotic formula gives modest relief to Crohn's sufferers
This study suggests a specific three‑strain probiotic may help some people with Crohn’s disease feel slightly better and absorb certain nutrients better, even though it didn’t reduce core disease activity.
Nutritional status and quality of life matter to many people with Crohn’s, so these secondary benefits could be relevant alongside medical care.
Adults with Crohn’s disease, caregivers worried about nutrition, and clinicians interested in adjunctive dietary supplements or microbiome approaches.
What To Know
What to know A small clinical study from Lebanon tested a three‑strain probiotic product (Trilac) in 21 adults with Crohn’s disease over eight weeks. The researchers reported no reduction in major disease symptoms or flare frequency, but saw modest improvements in quality-of-life scores and some measures of nutrient absorption (calcium, riboflavin, folate).
The probiotic used in the study was described by strain names (Lactobacillus acidophilus, Lactococcus bacillus, Bifidobacterium bifidum) and a manufacturer formulation (Trilac).
Participants kept their usual diets and treatments during the two‑month trial; the authors suggested probiotics might play an indirect role in supporting well‑being and nutritional status as part of broader, individualized care.
This report summarizes a single small, short‑duration trial published in Nutrients; it does not provide evidence that probiotics reduce Crohn’s disease activity or replace standard therapies. If you’re considering a probiotic, talk with your care team about product choice, expected benefits, and how it would fit with your current treatment plan.
This was a small (n=21), short (8‑week) trial reported in Nutrients. The study did not show changes in flare frequency or major symptom severity, and results may not generalize to other probiotic products or longer use. The article is from a supplement‑industry outlet and names a commercial product; the manufacturer was reported not to have funded the study.
